Remote patient care has been revolutionized by a fast-growing Internet of Medical Things (IoMT), which allows creating closed-loop therapeutic systems that automatically deliver drugs in response to real-time physiological measurements. Nevertheless, these mechanisms are confronted by a serious dual problem of not only the control of the doses precisely and as individual as possible but also of maintaining life-sensitive infrastructure against computer attacks that are becoming more and more advanced. The present paper presents the concept of a new and multi-layered IoT design, named SecureDose, which balances clinical efficacy with sound cybersecurity. SecureDose replaces intelligence to the Edge with a lightweight Long Short-Term Memory (LSTM) network to provide adaptive drug delivery and an ensemble Machine Learning-based Intrusion Detection System (IDS) to reduce threats in real-time.
The validity of the suggested architecture against conventional approaches is proved with experimental validation in terms of a Hardware-in-the-Loop (HIL) testbed. The LSTM-based controller demonstrated a Mean Absolute Error (MAE) of only 1.1mg/dl, which makes it significantly more effective than traditional PID controllers (4.2 mg/dL) and less likely to cause life-threatening drug overshoot to less than 1%. At the same time, Edge-hosted IDS has identified network traffic as malicious (99.2 percent), including DoS and Man-in-the-Middle attacks, and false positive rate was minimal (0.05). More importantly, an end-to-end latency of 112ms was sustained by the system, which is significantly below the 200ms safety margin necessary in critical care setting, demonstrating that very high-security requirements do not have to come at the cost of automating drug delivery systems.
Keywords: Internet of Medical Things (IoMT), Edge Computing, Intrusion Detection System (IDS), Automated Drug Delivery
How to cite this article: Suhas S, Lokesh S, Pradeep Kumar HS, Chaudhry P, Jakkani AK, Durairaj M, Robust and Secure IoT Architecture for Machine Learning-Based Drug Administration in Remote Healthcare. Int J Drug Deliv Technol. 2026;16(4s): 665-675; DOI: 10.25258/ijddt.16.4s.78
Source of support: Nil
Conflict of interest: None